Joanna Wiśniewska-Kruk explores the role of plasmalemma vesicle-associated protein (PLVAP) in the development and progression of diabetic retinopathy (DR). Diabetic retinopathy is a multifactorial disease that can progress from minor changes in vascular permeability, into a vision-threatening proliferative retinal disorder. Elucidation of the functions of PLVAP in endothelium and its possible implication in the development of DR may help to develop new, more effective therapeutic approaches in the clinic.
J. Wiśniewska-Kruk, PLVAP in Diabetic Retinopathy: A Gatekeeper of Angiogenesis and Vascular Permeability.
Prof. R.O. Schlingemann
Prof. C.J.F. van Noorden
Dr I. Klaassen
This event is open to the public.